Showing 3 posts of 3 posts found.

Janssen sign

Johnson & Johnson’s arthritis drug shows promising results in Phase III trial

March 16, 2021
Manufacturing and Production Janssen, Johnson & Johnson, PSA, Tremfya, arthritis

Johnson & Johnson’s TREMFYA treatment for active Psoriatic Arthritis (PsA) has returned positive results in its Phase III trial.

Novartis image

Novartis to present inflammatory data

November 10, 2014
Business Services AS, Novartis, PSA, Secukinumab, acr

Novartis is to present data from four pivotal Phase III trials in two debilitating inflammatory diseases at the American College …

AZ app image

AstraZeneca launches prostate cancer app

August 7, 2012
Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …

Latest content